Polidori, D., Mari, A., & Ferrannini, E. (2014). Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes. Springer Berlin Heidelberg.
Chicago-stil citatPolidori, David, Andrea Mari, och Ele Ferrannini. Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor, Improves Model-based Indices of Beta Cell Function in Patients With Type 2 Diabetes. Springer Berlin Heidelberg, 2014.
MLA-referensPolidori, David, Andrea Mari, och Ele Ferrannini. Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor, Improves Model-based Indices of Beta Cell Function in Patients With Type 2 Diabetes. Springer Berlin Heidelberg, 2014.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.